Skip to content

MEDKIDS: Nutritional Intervention With Improved Bread and Bakery Products in Children With Overweight and Obesity

"Investigación y Desarrollo de Nuevos Productos Alimentarios Para la elaboración de Una Cesta Saludable Para alimentación Infantil": MEDKIDS. Intervención Nutricional Con Productos de Pan y bollería.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07786675
Acronym
MEDKIDS
Enrollment
60
Registered
2026-08-26
Start date
2021-10-01
Completion date
2023-03-31
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Obesity

Keywords

mediterranean diet, dietary intervention, bakery products, whole grain, childhood obesity, gut microbiota, inflammation, lipid profile, satiety

Brief summary

The goal of this randomized crossover clinical trial is to evaluate the effect of an intervention with nutritionally improved bread and bakery products on body composition and metabolic health in children aged 6 to 12 years with overweight or obesity.

Detailed description

The main questions it aims to answer are: * Does consumption of reformulated bread and bakery products improve body composition compared to conventional products? * Does the intervention improve lipid profile, inflammatory markers, gastrointestinal satiety-related peptides, and gut microbiota composition? Researchers will compare conventional bakery products with reformulated products developed within the MEDKIDS project to determine their effects on anthropometric parameters, blood biomarkers, satiety, and intestinal microbiota. Participants will: * Follow a Mediterranean diet-based nutritional intervention with a 20% energy restriction adapted individually * Consume either conventional or reformulated bread and bakery products during two 8-week intervention periods separated by a 5-week washout * Undergo anthropometric assessments and blood, urine, and stool sample collection at the beginning and end of each period

Interventions

OTHERNutritionally improved bread and bakery products

Reformulated bread and bakery products developed within the MEDKIDS project with improved nutritional profile, including reduced saturated fat and free sugars and increased dietary fiber content compared to conventional products.

OTHERConventional bread and bakery products

Conventional bread and bakery products

Sponsors

Consorcio Centro de Investigación Biomédica en Red (CIBER)
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Masking description

This is an open-label dietary intervention; masking is not feasible due to the nature of the food products.

Intervention model description

Randomized two-period crossover trial with two 8-week intervention periods separated by a 5-week washout.

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 to 12 years. * Overweight or obesity defined according to Cole et al. criteria. * Willingness and commitment to consume the study bread and bakery products as part of the nutritional intervention. * Written informed consent provided by a parent or legal guardian.

Exclusion criteria

* Diagnosed disorders related to glucose metabolism (e.g., diabetes mellitus). * Celiac disease. * Gastrointestinal disorders, including inflammatory bowel disease. * Current medical or pharmacological treatment that may interfere with the study outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Changes in body weightBaseline and end of each 8-week intervention periodChange in body weight using bioelectrical impedance analysis with Tanita BC 780 MA scale. Unit of measure: kg
Change in heightBaseline and end of each 8-week intervention periodChange in height measured using a Seca 225 precision stadiometer according to standardized anthropometric procedures. Unit of measure: cm
Change in body mass indexBaseline and end of each 8-week intervention periodChange in body mass index calculated from body weight and height. Unir of measure: kg/m².
Change in body fat massBaseline and end of each 8-week intervention periodChange in body fat mass using bioelectrical impedance analysis with a Tanita BC 780 MA scale. Unit of measure: kg
Change in lean body massBaseline and end of each 8-week intervention periodChange in lean body mass using bioelectrical impedance analysis with a Tanita BC 780 MA scale. Unit of measure: Kg.
Change in total body waterBaseline and end of each 8-week intervention periodChange in total body water measured using bioelectrical impedance analysis with a Tanita BC 780 MA scale. Unir of measure: %
Changes in triceps and subscapular skinfold thicknessBaseline and end of each 8-week intervention periodChange in triceps and subscapular skinfold thickness measured in millimeters using a Holtain skinfold caliper according to standardized anthropometric procedures and International Society for the Advancement of Kinanthropometry (ISAK) recommendations. Three measurements will be performed.
Changes in blood biochemical, lipid and inflammatory parametersBaseline and end of each 8-week intervention periodChanges in blood chemical, lipid, and inflammatory parameters measured from fasting blood samples. Biochemical parameters include glucose, total proteins, calcium, iron, and zinc concentrations. Lipid parameters include total cholesterol, HDL cholesterol, LDL cholesterol triglycerides, apolipoprotein A1, and apolipoprotein B. Inflammatory parameters include C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10), complement component 3 (C3), and complement component 4 (C4).
Changes in gut microbiota composition and diversityBaseline and end of each 8-week intervention periodChanges in gut microbiota composition and diversity assessed from stool samples using metagenomic analysis following consumption of nutritionally improved versus conventional bread and bakery products.
Changes in satiety-related measuresBaseline and end of each 8-week intervention periodChanges in circulating satiety-related gastrointestinal hormones measured from fasting blood samples. Gastrointestinal hormones include insulin, leptin, ghrelin, glucose-dependent insulinotropic polypeptide (GIP), pancreatic polypeptide (PP), and glucagon-like peptide-1 (GLP-1).
Change in arm, waist and hip circumferenceBaseline and end of each 8-week intervention periodChange in arm, waist and hip circumference circumference measured in centimeters using a measuring tape according to standardized anthropometric procedures and International Society for the Advancement of Kinanthropometry (ISAK) recommendations. Three measurements will be performed.

Secondary

MeasureTime frameDescription
Changes in sensory acceptabilityBaseline and week 8Changes in sensory acceptability assessed in the applied nutrition sensometry substudy using a nine-point hedonic scale. Participants rated the pleasantness of three characteristic aromas (chocolate, grass, and n-butanol) under standardized conditions after consumption of a standardized breakfast. Participants also indicated whether each aroma was familiar and completed an exploratory assessment of mood and emotions before and after food consumption using emoticons.

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORLuis A Moreno

Growth, Exercise, Nutrition and Development (GENUD) Research Group, University of Zaragoza (Spain)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026